Relationship between time spent at extreme International Normalized Ratios and time in therapeutic range with bleeding and thrombosis in warfarin-treated patients-Reference-Cited by-同舟云学术

Relationship between time spent at extreme International Normalized Ratios and time in therapeutic range with bleeding and thrombosis in warfarin-treated patients

Published:2015-07-15 Issue:14 Volume:72 Page:1188-1194
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Barta Ashley L.¹,Nutescu Edith A.²,Thompson Paul A.³,Bussey Henry I.⁴,Gulseth Michael P.⁵

Affiliation:

1. Sanford USD Medical Center, Sioux Falls, SD; when this project was conducted she was Postgraduate Year 1 Resident, Sanford USD Medical Center

2. Department of Pharmacy Systems Outcomes and Policy, and Co-Director, Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago College of Pharmacy, Chicago

3. Methodology and Data Analysis Center, and Professor, Department of Pediatrics, Sanford School of Medicine, Sanford Research, Sioux Falls

4. ClotCare.org, San Antonio, TX, and President, Genesis Clinical Research, San Antonio

5. Sanford USD Medical Center, and Adjunct Assistant Professor, College of Pharmacy, South Dakota State University, Sioux Falls

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/72/14/1188/28338997/ajhp1188.pdf

Reference24 articles.

1. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians evidence-based clinical practice guidelines;Holbrook;Chest,2012

2. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of International Normalized Ratio control achieved by centers and countries as measured by time in therapeutic range;Connolly;Circulation,2008

3. Quality of anticoagulation control among patients with atrial fibrillation;Melamed;Am J Manag Care,2011

4. Comparison of two different models of anticoagulation management services with usual medical care;Rudd;Pharmacotherapy,2010

5. Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study;Singer;Circ Cardiovasc Qual Outcomes,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A smartphone application for remote adjustment of warfarin dose: Development and usability study;Applied Nursing Research;2022-02

2. Anticoagulation Control in Different Ethnic Groups Receiving Vitamin K Antagonist for Stroke Prevention in Atrial Fibrillation;Frontiers in Cardiovascular Medicine;2021-11-16

3. Influence of age on the relationship between apixaban concentration and anti-factor Xa activity in older patients with non-valvular atrial fibrillation;International Journal of Cardiology;2021-05

4. Poor Quality of Warfarin Treatment Increases the Risk of All Types of Intracranial Hemorrhage in Atrial Fibrillation;Circulation Journal;2019-02-25

5. Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore;Journal of Clinical Medicine;2018-05-01